Amit Sarpatwari

We have one of the most robust innovation systems in the world, and that system in pharmaceuticals really relies on

early-stage funding by the government of science, of medical research.

You can think of it as really ushering in this era that we have now of

of targeted therapies, targeted cancer drugs on the market.

There's now over 100 targeted cancer drugs on the market, which in many cases have meaningfully improved overall survival and quality of life.